BY Ferdinandos Skoulidis, M.D., Ph.D.

I vividly recall the moment when a text alert transformed an ordinary Friday into an extraordinary one. 

It happened on May 28, 2021. I was examining a patient in clinic when my cell phone began buzzing in my pocket. 

The Food and Drug Administration (FDA) was texting with some welcomed news. The agency had just approved a new drug for the treatment of non-small cell lung cancer, which...

Ferdinandos Skoulidis, M.D., Ph.D., conducting laboratory research while wearing his white coat and medical-grade face mask